High-risk nonmuscle invasive bladder cancer.
Please also verify that the expansion of HGT1 is OK as set: The risk of progression for high-grade T1 (HGT1) cancer has been recently established at 21% using updated information on large series and a meta-analysis. These outcomes are better than those classically expected supporting the rule of thirds for HGT1. The main limitation of this subgroup is that most studies are retrospective observational studies, which, compared with randomized controlled trials, are subject to various selection biases, carrying a higher risk of uncontrolled confounding factors, with potential preferential reporting of positive findings.
['Orsola|Anna|A|', 'Palou|Joan|J|', 'Solsona|Eduardo|E|']
D019468:Disease Management D006801:Humans D009361:Neoplasm Invasiveness D009367:Neoplasm Staging D011379:Prognosis D012306:Risk D001749:Urinary Bladder Neoplasms
Nonmuscle invasive bladder cancer HGT1 High-grade T1 CIS Carcinoma in situ High-risk bladder cancer TUR reTUR